SCHEMBL14342999

SCHEMBL14342999

Nc1cccc(Oc2ccc3c(c2)Cc2cc(Oc4cccc(N)c4)ccc2-3)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.58
▸ ATM Q13315 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.50
▸ MAPT P10636 4/20 0.50
▸ RAB9A P51151 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ MITF O75030 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ NLRP1 Q9C000 1/20 0.50
▸ NOD2 Q9HC29 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ POLB P06746 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ CYP3A4 P08684 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14342967 0.87 ALDH1A1 (0.60) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL14343044 0.83 ALDH1A1 (0.56) MAOBALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL14343002 0.83 ALDH1A1 (0.56) MAOBALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL14343201 0.82 ALDH1A1 (0.50) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL8896838 0.81 MAOB (0.50) MAOBALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL29363390 0.80 MAOB (0.86) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL204267 0.80 MAOB (0.86) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL128748 0.80 MAOB (0.86) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL29352463 0.80 MAOB (0.86) MAOBATMALDH1A1MAPTRAB9A
SCHEMBL1270913 0.80 MAOB (0.86) MAOBATMALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2692775-B1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE- ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORP (JP) 2015-04-08 — — EP disclosed
US-20140235896-A1 NOVEL DIAMINE COMPOUND NITTO DENKO CORPORATION (JP) 2014-08-21 — — US disclosed
US-8748664-B2 Diamine compound and production method thereof NITTO DENKO CORPORATION (JP) 2014-06-10 — — US disclosed
EP-2692775-A1 POLYIMIDE, POLYIMIDE POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, AND SOLID POLYMER FUEL CELL Nitto Denko Corporation (JP) 2014-02-05 — — EP disclosed
US-20130171541-A1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORPORATION (JP) 2013-07-04 — — US disclosed
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF NITTO DENKO CORPORATION (JP) 2013-01-03 — — US disclosed
EP-2540699-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF Nitto Denko Corporation (JP) 2013-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF AOC1, SAT1, ODC1 MAOB 672/4885ATM 3040/4885ALDH1A1 100/4885
US-20140235896-A1 NOVEL DIAMINE COMPOUND AOC1, SAT1, ARG1 MAOB 912/4885ATM 2848/4885ALDH1A1 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback